NTLA
Intellia Therapeutics, Inc
$14.55
-8.11%
-1.29
Notify me if price changes either direction
Buy NTLA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.7B
Enterprise value
1.4B
Trailing PE
-2.7847618829636
Forward PE
-4.148812
PEG Ratio
0.088847164837411
Enterprise to EBITDA
-3.048
Enterprise to revenue
24.833
Price to book MRQ
2.306621
Price to sales TTM
30.020586
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
57.5M
EBITDA
-468774016
Diluted EPS TTM
-4.25
Total Cash (MRQ)
511.0M
Current ratio (MRQ)
6.209
Operating Cash Flow (TTM)
-410646016
NTLA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
